Healthcare Resources for Professionals

End-Stage Pulmonary Disease:
Guidelines for End-Stage Pulmonary Disease & Related Disorders

LIFE-LIMITING CONDITION AS EVIDENCED BY:

  • Dyspnea at rest and on exertion.
  • Severe cough.
  • Copious/purulent sputum.


SIGNS:

  • Cyanosis: blue lips, fingertips.
  • Retractions.
  • Oxygen dependence.
  • Depressed diaphragm.
  • Accessory muscles of respiration.
  • Pulmonary hyperinflation: barrel-chested.
  • Increased expiratory phase: slowed forced expiration.
  • Increased hospitalization for pulmonary infections/respiratory failure.
  • Decrease in FEV1 on serial testing of greater than 40 mL per year*.
  • Presence of cor pulmonale or right heart failure due to lung disease.
  • Forced expiratory volume in one second (FEV1) after bronchodilator, less than 30% of predicted*.
  • Pursed-lip breathing.
  • Wheezing.
  • Recurrent infections.
  • Poor response to bronchodilators.
  • Diminished breath sounds.
  • Increased visits to Emergency Department.


EVIDENCED BY:

  • Echocardiographic documentation.
  • Chest x-ray.
  • Hypoxemic at rest on supplemental oxygen.
  • Unintentional weight loss > 10% of body weight in past six months.
  • Resting tachycardia (heart rate > 100 per minute).
  • EKG*
  • Physical signs of RHF

* These tests are helpful evidence but should not be required if not readily available.


HOW WE HELP END-STAGE PULMONARY DISEASE:

  • Increased quality of life.
  • Medication to relieve nausea, pain or shortness of breath.
  • Coordination of comfort measures for patient including durable medical equipment and non-medical therapies.
  • Education for the patient and family as disease progresses.
  • Psychosocial support for patient and the family.
  • Spiritual care and support for the patient and the family.